What is NewPath Labs?
NewPath Labs, a specialized division of Newport Harbor Pathology Medical Group, Inc., is dedicated to delivering high-caliber pathology services directly to physician offices and ambulatory centers. As the exclusive pathology provider for Hoag Hospital Newport Beach and Hoag Hospital Irvine, the company ensures rapid and precise diagnostic outcomes. Their team of board-certified pathologists possesses extensive expertise across various subspecialties, consistently achieving results within one business day for approximately 97% of cases. NewPath Labs cultivates robust partnerships with healthcare professionals, fostering efficient collaboration and responsive support.
How much funding has NewPath Labs raised?
NewPath Labs has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in NewPath Labs
PPP
Public-Private Partnership
What's next for NewPath Labs?
The substantial enterprise-level funding indicates a strategic phase of expansion and operational enhancement for NewPath Labs. This capital infusion is likely to support the scaling of its diagnostic capabilities, technological advancements in pathology, and the broadening of its service reach to more healthcare providers. The company's focus on efficiency and accuracy, coupled with its exclusive partnerships, positions it for continued growth and leadership in the competitive pathology market.
See full NewPath Labs company page
